| Molecule | Cat. No. | Product Name | Species | Host | Structure | Purity | Activity | Size&Price | Add to Cart |
|---|---|---|---|---|---|---|---|---|---|
| Sortilin | Cynomolgus Sortilin Protein, His Tag | Cynomolgus | HEK293 | ![]() | SDS-PAGE | $425.00 100ug | |||
| Sortilin | Canine Sortilin Protein, His Tag | Canine | HEK293 | ![]() | SDS-PAGE | $425.00 100ug | |||
| Sortilin | Human Sortilin / SORT1 Protein, His Tag, low endotoxin (MALS verified) | Human | HEK293 | ![]() | MALSSDS-PAGE | $425.00 100ug | |||
| Sortilin | Avitag SON-H82E9 | Biotinylated Human Sortilin / SORT1 Protein, His,Avitag™ (MALS & SPR verified) | Human | HEK293 | ![]() | MALSSDS-PAGE | $360.00 25ug | ||
| Sortilin | Rat Sortilin Protein, His Tag (MALS verified) | Rat | HEK293 | ![]() | MALSSDS-PAGE | $425.00 100ug |
| English Name | Research Code | Highest Development Stage | Company | Indication | Clinical Trial |
|---|---|---|---|---|---|
| VES-001 | VES001; VES-001 | Phase 2 Clinical | Vesper Bio APS | Dementia; Frontotemporal Dementia; Frontotemporal Lobar Degeneration | Details |
| Latozinemab | AL-001; GSK-4527223 | Phase 1 Clinical | Alector Inc, Glaxosmithkline Plc | Amyotrophic Lateral Sclerosis; Frontotemporal Dementia; Neurodegenerative Diseases | Details |
| ARB-1-6 | ARB-1-6; PQ-203 | Phase 1 Clinical | ProteinQure Inc | Breast Neoplasms; Solid tumours; Triple Negative Breast Neoplasms | Details |